Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Chemoradiotherapy for Rectal Cancer
NCT00346099Phase 2Withdrawn
- Sponsor
- NSABP Foundation
- Start
- Jun 2006
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of panitumumab in rectal cancer, sponsored by NSABP Foundation. Planned start Jun 2006; status: withdrawn.
02
Drugs
panitumumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00346099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346099.